Brief: Y-Mabs Reaches Agreement with EMA On The Pediatric Investigation Plan For Naxitamab
Feb 2 (Reuters) - Y-mAbs Therapeutics Inc YMAB.O :
* Y-MABS AND THE EUROPEAN MEDICINES AGENCY REACH AGREEMENT
ON THE
PEDIATRIC INVESTIGATION PLAN FOR NAXITAMAB
* Y-MABS AND EUROPEAN MEDICINES AGENCY REACH AGREEMENT ON
PEDIATRIC INVESTIGATION PLAN FOR NAXITAMAB
* Y-MABS THERAPEUTICS INC - DECISION FOLLOWS A POSITIVE
OPINION
FROM EMA'S PEDIATRIC COMMITTEE
Source text for Eikon: ID:nGNX6b2D6g
Further company coverage: YMAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Y-mAbs Therapeutics
See all newsY-mAbs Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Y-mAbs Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Y-mAbs Therapeutics' Q2 revenue falls 14%
Brief: Serb Pharmaceuticals Agrees To Acquire Y-Mabs Therapeutics
Y-mAbs Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary